Akmaev VR - Search Results

1

Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis.

Curtis JR, Strand V, Golombek SJ, Karpouzas GA, Zhang L, Wong A, Patel K, Dines J, Akmaev VR. Curtis JR, et al. Among authors: akmaev vr. Rheumatol Ther. 2024 Feb;11(1):61-77. doi: 10.1007/s40744-023-00618-1. Epub 2023 Nov 10. Rheumatol Ther. 2024. PMID: 37948030 Free PMC article.

2

Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis.

Curtis JR, Strand V, Golombek S, Zhang L, Wong A, Zielinski MC, Akmaev VR, Saleh A, Asgarian S, Withers JB. Curtis JR, et al. Among authors: akmaev vr. Expert Rev Mol Diagn. 2022 Nov 3:1-10. doi: 10.1080/14737159.2022.2140586. Online ahead of print. Expert Rev Mol Diagn. 2022. PMID: 36305319 Free article.

3

Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis.

Cohen S, Curtis JR, Mellors T, Zhang L, Withers JB, Jones A, Ghiassian SD, Akmaev VR. Cohen S, et al. Among authors: akmaev vr. Rheumatol Ther. 2023 Feb;10(1):1-6. doi: 10.1007/s40744-022-00506-0. Epub 2022 Nov 27. Rheumatol Ther. 2023. PMID: 36441482 Free PMC article.

4

The module triad: a novel network biology approach to utilize patients' multi-omics data for target discovery in ulcerative colitis.

Voitalov I, Zhang L, Kilpatrick C, Withers JB, Saleh A, Akmaev VR, Ghiassian SD. Voitalov I, et al. Among authors: akmaev vr. Sci Rep. 2022 Dec 15;12(1):21685. doi: 10.1038/s41598-022-26276-x. Sci Rep. 2022. PMID: 36522454 Free PMC article.

5

A Network-Based Framework to Discover Treatment-Response-Predicting Biomarkers for Complex Diseases.

Shanthamallu US, Kilpatrick C, Jones A, Rubin J, Saleh A, Barabási AL, Akmaev VR, Ghiassian SD. Shanthamallu US, et al. Among authors: akmaev vr. J Mol Diagn. 2024 Oct;26(10):917-930. doi: 10.1016/j.jmoldx.2024.06.008. Epub 2024 Jul 25. J Mol Diagn. 2024. PMID: 39067570 Free article.

6

Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients.

Subbiah V, Yu PP, Sarangarajan R, Kiebish MA, Rodrigues LO, Miller GM, Akmaev VR, Luan S, McCook JP, Tanna N, Reilly T, Chen E, Bussberg V, Ravipaty S, Vishnudas VK, Gesta S, Lucius D, Bruce C, Hazarika S, Lyng A, Klotz A, Tolstikov V, Stevens J, Chua VS, Granger E, Tekumalla PK, Benaim E, Modur V, Rudoltz MS, Song PY, Tagawa ST, Hendifer A, Chawla SP, Shah MA, Hong DS, Zinner R, Narain NR, Kundranda MN. Subbiah V, et al. Among authors: akmaev vr. Cancer Res Commun. 2025 Dec 1;5(12):2207-2223. doi: 10.1158/2767-9764.CRC-25-0507. Cancer Res Commun. 2025. PMID: 41251181 Free PMC article. Clinical Trial.

7

Retraction notice to "Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis" Translational Research 239C (2021) 35-43.

Akmaev VR, Ghiassian SD, Withers JB, Santolini M, Saleh A. Akmaev VR, et al. Transl Res. 2022 Jun;244:137. doi: 10.1016/j.trsl.2022.03.011. Transl Res. 2022. PMID: 35589246 No abstract available.

8

Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis.

Ghiassian SD, Voitalov I, Withers JB, Santolini M, Saleh A, Akmaev VR. Ghiassian SD, et al. Among authors: akmaev vr. Transl Res. 2022 Aug;246:78-86. doi: 10.1016/j.trsl.2022.03.006. Epub 2022 Mar 16. Transl Res. 2022. PMID: 35306220 Free article.

9

A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.

Cohen S, Akmaev VR, Withers JB, Connolly-Strong E. Cohen S, et al. Among authors: akmaev vr. Rheumatol Ther. 2022 Feb;9(1):309-311. doi: 10.1007/s40744-021-00387-9. Epub 2021 Nov 10. Rheumatol Ther. 2022. PMID: 34757533 Free PMC article. No abstract available.

10

Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis.

Jones A, Rapisardo S, Zhang L, Mellors T, Withers JB, Gatalica Z, Akmaev VR. Jones A, et al. Among authors: akmaev vr. Expert Rev Mol Diagn. 2021 Nov;21(11):1235-1243. doi: 10.1080/14737159.2021.2000394. Epub 2021 Nov 10. Expert Rev Mol Diagn. 2021. PMID: 34727834 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters